GSTP1 and systemic lupus erythematosus: Concerning SLE, Zhong et al. observed that the GSTP1 codon 105 polymorphism significantly increased the risks of short-term ADRs, including myelotoxicity and gastro-intestinal toxicity among 102 patients treated with CYC [21].